Adherence to rivaroxaban for the treatment of venous thromboembolism–Results from the FIRST registry

Adherence to rivaroxaban for the treatment of venous thromboembolism–Results from the FIRST registry

Abstract Background Medication nonadherence can result in poor clinical outcomes and significant costs to health care providers. When treating venous thromboembolism (VTE), subtherapeutic anticoagulation may contribute to complications such as recurrent VTE or postthrombotic syndrome. Objectives To...

Full description

Bibliographic Details
Main Authors: Victoria Speed, Vivian Auyeung, Jignesh P. Patel, Derek Cooper, Stephen Miller, Lara N. Roberts, Raj K. Patel, Roopen Arya
Format: Article
Language:English
Published: Elsevier 2021-12-01
Series:Research and Practice in Thrombosis and Haemostasis
Subjects:
anticoagulants
medication adherence
rivaroxaban
venous thromboembolism
Online Access:https://doi.org/10.1002/rth2.12614

Internet

https://doi.org/10.1002/rth2.12614

Similar Items